Fourteen elderly depressive patients (age 67-88 yr), phenotyped with dextromethorphan and rnephenytoin before and during the trial, were treated for 4 weeks with citalopram (final dose 20-30 mg/day, except one patient 60 mg/day). The clinical state of the patients was recorded weekly using the Hamil
Citalopram treatment of paroxetine-intolerant depressed patients
โ Scribed by Michael E. Thase; James M. Ferguson; R. Bruce Lydiard; Charles S. Wilcox
- Publisher
- John Wiley and Sons
- Year
- 2002
- Tongue
- English
- Weight
- 105 KB
- Volume
- 16
- Category
- Article
- ISSN
- 1091-4269
- DOI
- 10.1002/da.10055
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
## Abstract ## Objective The efficacy and tolerability of paroxetine in the treatment of depressive disorders is well known, however, its efficacy and safety for the treatment of depression in patients with cancer has been poorly studied. Therefore this study was aimed at evaluating the efficacy a
## Abstract In the present study, we examined the effects of acute treatment with paroxetine on the consumption of cigarette smoking and caffeine in 65 patients who met the DSMโIV criteria for major depressive disorder (M/F: 28/37, age: 48โยฑโ15 years). Plasma levels of cotinine or caffeine were ana